BR0313044A - Compostos orgânicos - Google Patents
Compostos orgânicosInfo
- Publication number
- BR0313044A BR0313044A BR0313044-4A BR0313044A BR0313044A BR 0313044 A BR0313044 A BR 0313044A BR 0313044 A BR0313044 A BR 0313044A BR 0313044 A BR0313044 A BR 0313044A
- Authority
- BR
- Brazil
- Prior art keywords
- organic compounds
- crystalline forms
- methylthiophene
- dodecahydro
- cyclopenta
- Prior art date
Links
- 150000002894 organic compounds Chemical class 0.000 title abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0217504.0A GB0217504D0 (en) | 2002-07-29 | 2002-07-29 | Organic compounds |
| PCT/EP2003/008314 WO2004013156A1 (en) | 2002-07-29 | 2003-07-28 | Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (a) phenanthrenyl ester |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0313044A true BR0313044A (pt) | 2005-06-14 |
Family
ID=9941275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0313044-4A BR0313044A (pt) | 2002-07-29 | 2003-07-28 | Compostos orgânicos |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7683048B2 (https=) |
| EP (2) | EP1554303B1 (https=) |
| JP (1) | JP2006501207A (https=) |
| KR (1) | KR100688371B1 (https=) |
| CN (1) | CN1305892C (https=) |
| AR (1) | AR040692A1 (https=) |
| AT (1) | ATE349459T1 (https=) |
| AU (1) | AU2003251651B2 (https=) |
| BR (1) | BR0313044A (https=) |
| CA (1) | CA2493330C (https=) |
| CY (1) | CY1106406T1 (https=) |
| DE (1) | DE60310747T2 (https=) |
| DK (1) | DK1554303T3 (https=) |
| EC (1) | ECSP055579A (https=) |
| ES (1) | ES2279970T3 (https=) |
| GB (1) | GB0217504D0 (https=) |
| HK (1) | HK1080484B (https=) |
| IL (2) | IL166287A0 (https=) |
| MX (1) | MXPA05001173A (https=) |
| MY (1) | MY136407A (https=) |
| NO (1) | NO20050806L (https=) |
| NZ (2) | NZ549713A (https=) |
| PE (1) | PE20040722A1 (https=) |
| PL (1) | PL209409B1 (https=) |
| PT (1) | PT1554303E (https=) |
| RU (2) | RU2348646C1 (https=) |
| SI (1) | SI1554303T1 (https=) |
| TW (1) | TWI309164B (https=) |
| WO (1) | WO2004013156A1 (https=) |
| ZA (1) | ZA200500370B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| WO2002012266A1 (en) | 2000-08-05 | 2002-02-14 | Glaxo Group Limited | 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| PT1383786E (pt) | 2001-04-30 | 2008-12-30 | Glaxo Group Ltd | Derivados anti-inflamatórios de éster 17.beta-carbotioato de androstano com um grupo éster ciclíco na posição 17.alfa |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| GB0523656D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0523654D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0603783D0 (en) * | 2006-02-24 | 2006-04-05 | Novartis Ag | Organic compounds |
| BRPI0909288A2 (pt) * | 2008-03-14 | 2015-08-18 | Otsuka Pharma Co Ltd | Inibidores da mmp-2 e/ou da mmp-9 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU550939A1 (ru) * | 1975-05-19 | 1994-07-15 | Институт химии древесины АН ЛатвССР | 1,2,3,4,4а,4в,5,6,10,10а -декагидро -6- хлорацетоксиметил -1,4а-диметил -7- (1-метилэтил) -1- фенантренкарбоновая кислота или ее соли |
| JPH08291073A (ja) * | 1995-04-22 | 1996-11-05 | Kissei Pharmaceut Co Ltd | 医薬品組成物及びその製造方法 |
| GB0015876D0 (en) * | 2000-06-28 | 2000-08-23 | Novartis Ag | Organic compounds |
-
2002
- 2002-07-29 GB GBGB0217504.0A patent/GB0217504D0/en not_active Ceased
-
2003
- 2003-07-25 PE PE2003000741A patent/PE20040722A1/es not_active Application Discontinuation
- 2003-07-25 AR AR20030102680A patent/AR040692A1/es unknown
- 2003-07-28 KR KR1020057001581A patent/KR100688371B1/ko not_active Expired - Fee Related
- 2003-07-28 PT PT03766325T patent/PT1554303E/pt unknown
- 2003-07-28 JP JP2004525343A patent/JP2006501207A/ja active Pending
- 2003-07-28 PL PL373140A patent/PL209409B1/pl not_active IP Right Cessation
- 2003-07-28 CN CNB038180596A patent/CN1305892C/zh not_active Expired - Fee Related
- 2003-07-28 DE DE60310747T patent/DE60310747T2/de not_active Expired - Lifetime
- 2003-07-28 SI SI200330721T patent/SI1554303T1/sl unknown
- 2003-07-28 TW TW092120513A patent/TWI309164B/zh not_active IP Right Cessation
- 2003-07-28 AU AU2003251651A patent/AU2003251651B2/en not_active Ceased
- 2003-07-28 EP EP03766325A patent/EP1554303B1/en not_active Expired - Lifetime
- 2003-07-28 BR BR0313044-4A patent/BR0313044A/pt not_active IP Right Cessation
- 2003-07-28 AT AT03766325T patent/ATE349459T1/de active
- 2003-07-28 RU RU2007143025/04A patent/RU2348646C1/ru not_active IP Right Cessation
- 2003-07-28 EP EP06005390A patent/EP1676854A1/en not_active Withdrawn
- 2003-07-28 RU RU2005105688/04A patent/RU2330043C2/ru not_active IP Right Cessation
- 2003-07-28 DK DK03766325T patent/DK1554303T3/da active
- 2003-07-28 MY MYPI20032832A patent/MY136407A/en unknown
- 2003-07-28 NZ NZ549713A patent/NZ549713A/en unknown
- 2003-07-28 MX MXPA05001173A patent/MXPA05001173A/es active IP Right Grant
- 2003-07-28 ES ES03766325T patent/ES2279970T3/es not_active Expired - Lifetime
- 2003-07-28 CA CA2493330A patent/CA2493330C/en not_active Expired - Fee Related
- 2003-07-28 HK HK06100247.5A patent/HK1080484B/en not_active IP Right Cessation
- 2003-07-28 US US10/522,358 patent/US7683048B2/en not_active Expired - Fee Related
- 2003-07-28 WO PCT/EP2003/008314 patent/WO2004013156A1/en not_active Ceased
- 2003-07-28 NZ NZ537868A patent/NZ537868A/en unknown
-
2005
- 2005-01-13 IL IL16628705A patent/IL166287A0/xx unknown
- 2005-01-14 ZA ZA200500370A patent/ZA200500370B/en unknown
- 2005-01-26 EC EC2005005579A patent/ECSP055579A/es unknown
- 2005-02-15 NO NO20050806A patent/NO20050806L/no unknown
-
2007
- 2007-03-22 CY CY20071100400T patent/CY1106406T1/el unknown
- 2007-07-26 IL IL184848A patent/IL184848A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003202044A1 (en) | 17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents | |
| BRPI0409133A (pt) | formulações farmacêuticas contendo metilnaltrexona | |
| DE60230327D1 (de) | Polymorphe von clopidogrel-hydrogensulfat | |
| BR0315547A (pt) | Derivados de quinolina como antagonistas de crth2 | |
| MXPA06000407A (es) | Isomero c cci-779. | |
| DE502004012095D1 (de) | Verfahren zum herstellen von 2-dihalogenacyl-3-amino-acryls ureestern und 3-dihalogenmethyl-pyrazol-4-carbons ureestern | |
| DE602005013248D1 (de) | Amidderivate von 3-phenyldihydropyrimidoä4,5-düpyrimidinonen, deren herstellung und verwendung als pharmazeutische mittel | |
| BR0108396A (pt) | Derivados de pirimidina-4-0na como inibidores de ldl-pla(2) | |
| AU3850600A (en) | Dalda analogs and their use | |
| BR0313044A (pt) | Compostos orgânicos | |
| WO2004093800A3 (en) | Thyronamine derivatives and analogs and methods of use thereof | |
| ATE331713T1 (de) | Verfahren zur herstellung von 5-nitrobenzofuranen | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| CY1109376T1 (el) | Παραγωγα υδαντοϊνης χρησιμα ως αναστολεις μεταλλοπρωτεϊνασης | |
| HUP0203385A2 (en) | Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| AU2003246829A1 (en) | Solvent-based sterilisation of pharmaceuticals | |
| UY27491A1 (es) | Derivados de ácido acético | |
| DE60015508T2 (de) | C-16 ungesätigte fp-selektive prostaglandin analoge | |
| MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides | |
| EA200700144A1 (ru) | Производные пиридопиримидина, их получение, их применение в терапии | |
| DE60100855D1 (de) | 1,8-naphthalimid imidazo[4,5,1-de]acridone mit antitumorwirkung | |
| DE60107832D1 (en) | Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe | |
| AR014738A1 (es) | Nuevo procedimiento de preparacion de la fexofenadina y compuestos intermediarios | |
| ATE226585T1 (de) | Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen | |
| SE0301445D0 (sv) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07F | Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette] |
Free format text: NOTIFICACAO DE NAO ANUENCIA RELACIONADA COM O ART. 229 DA LPI |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 12A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2316 DE 26-05-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |